Envirotainer invests and expands capacity
By the end of 2022, Envirotainer will be capable of shipping over one billion vials per year
Envirotainer, the global market leader in secure cold chain solutions for shipment of pharmaceuticals, has expanded its production site in Rosersberg, north of Stockholm.
"This is in response to incredibly high demand for secure, temperature-controlled units to transport vital medicines around the globe. This year alone, the business will add annual shipping capacity of ~200 million more doses. By the end of 2022, Envirotainer will be capable of shipping over one billion vials per year," says an official release.
The site is the largest in the world in terms of output, able to build more units each year. It has also been designed to allow further expansion in the future, the release said.
"The Envirotainer fleet covers more than 2,000 pharmaceutical trade lanes in over 100 countries and 300 airports. Its services help pharma companies meet the strictest requirements in pharmaceutical air freight and include the new Releye® RAP and RLP models, which are the largest and most advanced of their type on the market, combining high capacity with superior features."
Peter Gisel-Ekdahl, CEO, Envirotainer, opened the expanded facility this month.
Bernt Anderberg, Chief Technology and Supply Chain Officer, says: "I'm immensely proud of the team's outstanding efforts and happy to be stepping up production."
Sofie Nordhamren, Head of Quality Control and Production Manager, Envirotainer adds: "The demand for our services has been sky-high since the start of the pandemic. The need to safely transport pharmaceuticals while minimising wasted space in precious air cargo has increased dramatically.
"The added capacity will help our customers be more efficient, sustainable, and reduce the likelihood of a temperature deviation to virtually zero. This nearly eliminates the likelihood of valuable product loss."